Companies: 10,795·Total market cap: $144.5T
Elevation Oncology, Inc.

Elevation Oncology, Inc.

ELEVNASDAQHealthcare
$0.37
$-0.01(-2.12%)
Market Cap$21627309
P/E Ratio
52W High$3.09
52W Low$0.221
Overview

Elevation Oncology, Inc. (ELEV) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · ELEV · as of Jun 9, 2026

Key Statistics

EPS (TTM)$-0.82elev eps ttm · elev earnings per shareEarnings history
PE Ratio (TTM)elev pe ratio ttm · elev price to earningsPE Ratio deep dive
Revenue (TTM)38000.00elev revenue ttm · elev annual revenueFull revenue history
Dividend YieldNo Dividenddoes elev pay dividends · elev dividend yieldDividend history
Shares Outstanding57.3Melev shares outstanding · elev floatShares outstanding history
Next EarningsTBAelev earnings date · elev next earningsEarnings history

Financial Snapshot

Full Financials
FY 2024Revenue$0.00
202220232024
elevation oncology, inc. revenue · elev revenue 2024
FY 2024Net Income-$44.5M▲ +2.67% YoY
202220232024
elevation oncology, inc. net income · elev profit 2024
FY 2024EPS$-0.78▲ +41.79% YoY
202220232024
elev eps · elevation oncology, inc. earnings per share 2024
TTM:Revenue: $38000.00Net Income: -$48.0MEPS: $-0.82View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Hold12 analystsis elev a buy · elev analyst rating
Strong Buy
0
Buy
3
Hold
8
Sell
1
Strong Sell
0
12-Month Price Target
$8.00Low
$0.36Current
$9.00Avg Target2365.75% upside
$10.00High
elev price target · elev 12 month forecast

Total: 12 · Buy rate: 25.0%

The ELEV analyst consensus is Hold, based on ratings from 12 Wall Street analysts over the past 3 months. The average 12-month price target is $9.00, representing +2365.75% upside from the current price of $0.36.

Stock Performance

Full History
1D+0.00%
1W+0.00%
1M+0.00%
3M+13.71%
YTD-38.67%
1Y-54.38%
5Y-96.81%

About Elevation Oncology, Inc.

CEOJoseph J. Ferra Jr.
IPO DateJun 25, 2021
Employees34
CountryUS

Elevation Oncology, Inc. is a clinical-stage biopharmaceutical company operating in the United States, committed to developing targeted cancer therapies for patients with specific genetic profiles. It…

what is elevation oncology, inc. · elev stock overview · elevation oncology, inc. company profile · who is elevation oncology, inc. ceo · elev NASDAQ · elevation oncology, inc. headquarters · elevation oncology, inc. business segments

About Stock Overview & Key Data

Elevation Oncology, Inc. (ELEV) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jun 25, 2021. As of the latest trading session, ELEV stock price is $0.36, with a market capitalization of $21.6M. The stock has returned -54.38% over the past 12 months and -38.67% year-to-date.

According to 12 Wall Street analysts, the consensus rating for Elevation Oncology, Inc. stock is Hold, with an average 12-month price target of $9.00. In fiscal year 2024, Elevation Oncology, Inc. reported revenue of — and net income of -$44.5M. For detailed data — including Elevation Oncology, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Elevation Oncology, Inc. (ELEV) stock price is $0.36. The stock is traded on NASDAQ under the ticker symbol ELEV. The 52-week range is $0.22 – $3.09.

ELEV stock priceELEV quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 9, 2026Not investment advice